Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
International Journal of Infectious Diseases
International Society for Infectious Diseases
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • World TB Day 2023
    • World TB Day 2022
    • World TB Day 2021
    • IJID COVID-19
    • Emerging Infectious Diseases in the Time of Ebola
    • Featured Content
  • For Authors
    • Back
    • About Open Access
    • Author Information
    • Permissions
    • Researcher Academy 
    • Submit a Manuscript 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact Information
    • Editorial Board
    • Info for Advertisers 
    • Reprints 
    • New Content Alerts
  • News and Media
  • ISID 
  • ProMED 
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Claim
x

Filter:

Filters applied

  • Coronavirus (COVID-19) Collection
  • Pranata, RaymondRemove Pranata, Raymond filter
  • CoronavirusRemove Coronavirus filter
  • 2017 - 2022Remove 2017 - 2022 filter
Clear all

Article Type

  • Research Article3

Author

  • Lim, Michael Anthonius2
  • Martha, Januar Wibawa2
  • Wibowo, Arief2
  • Akbar, Mohammad Rizki1
  • Akbara, Mohammad Rizki1
  • Lemuel, Theo Audi Yanto1
  • Lukito, Antonia Anna1
  • Lumbuun, Nicolaski1
  • Massie, Billy1
  • Meidy, Cindy1
  • Prasetya, Ignatius Bima1
  • Wahjoepramono, Eka Julianta1
  • Widysanto, Allen1
  • Yuniarti, Mira1
  • Yusuf, Irawan1

Journal

  • International Journal of Infectious Diseases3

Keyword

  • Thrombosis2
  • Acetylsalicylic acid1
  • Angiotensin1
  • Aspirin1
  • Candesartan1
  • Coagulopathy1
  • Endothelial dysfunction1
  • Mortality1
  • Outcome1
  • SARS-CoV-21
  • Severity1

Access Filter

  • Open Access

Coronavirus (COVID-19) Collection

3 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Research Article
    Open Access

    Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis

    International Journal of Infectious Diseases
    Vol. 117p267–273Published online: June 27, 2021
    • Arief Wibowo
    • Raymond Pranata
    • Michael Anthonius Lim
    • Mohammad Rizki Akbara
    • Januar Wibawa Martha
    Cited in Scopus: 9
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      Coronavirus disease 2019 (COVID-19) is currently one of the most common diseases in the world, and has a considerable death toll (WHO, 2021). Although most patients have mild–moderate clinical manifestations, a significant proportion of patients develop life-threatening complications (Lim et al., 2020; Pranata et al., 2020a, 2021c). Complications caused by coagulopathy are among the most important. Activation of the coagulation pathway and endothelial cells (ECs) is a hallmark of severe COVID-19, which is consistent with high rates of venous thromboembolism (VTE), pulmonary embolism (PE) and disseminated intravascular coagulation (DIC) (Mancini et al., 2021a; Ward et al., 2021).
      Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis
    • Research Article
      Open Access

      Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

      International Journal of Infectious Diseases
      Vol. 108p159–166Published online: May 22, 2021
      • Antonia Anna Lukito
      • Allen Widysanto
      • Theo Audi Yanto Lemuel
      • Ignatius Bima Prasetya
      • Billy Massie
      • Mira Yuniarti
      • and others
      Cited in Scopus: 3
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Coronavirus disease 2019 (COVID-19) is a global public health emergency (World Health Organization, 2021). Hundreds of millions of people have been infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at the time of writing. Although most patients with COVID-19 are asymptomatic or experience only mild influenza-like illness (Day, 2020), a significant proportion may develop severe pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure (MOF) and death (Lim et al., 2020).
        Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
      • Research Article
        Open Access

        Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates

        International Journal of Infectious Diseases
        Vol. 108p6–12Published online: May 14, 2021
        • Januar Wibawa Martha
        • Raymond Pranata
        • Michael Anthonius Lim
        • Arief Wibowo
        • Mohammad Rizki Akbar
        Cited in Scopus: 24
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Repurposing of available drugs for patients with coronavirus disease 2019 (COVID-19) has gained interest due to the scarcity of drugs proven to be useful in these patients. Dexamethasone, statins, metformin, dipeptidyl peptidase-4 inhibitors and renin–angiotensin system inhibitors have shown clinical benefits for severe and critically ill patients, especially those who are mechanically ventilated (Castiglione et al., 2020; Lim and Pranata, 2020a; Lukito et al., 2020; Pranata et al., 2020c; Rakhmat et al., 2021).
          Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates
        Page 1 of 1
        Skip menu

          Login to your account

          Show
          Forgot password?
          Don’t have an account?
          Create a Free Account

          If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

          If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

          Cancel
          • Home
          • Articles & Issues
          • Articles In Press
          • Current Issue
          • List of Issues
          • Supplements
          • Collections
          • IJID COVID-19
          • Emerging Infectious Diseases in the Time of Ebola
          • Featured Content
          • For Authors
          • About Open Access
          • Author Information
          • Permissions
          • Researcher Academy
          • Submit a Manuscript
          • Journal Info
          • About the Journal
          • About Open Access
          • Contact Information
          • Editorial Board
          • Info for Advertisers
          • Reprints
          • New Content Alerts
          • News and Media
          • ISID
          • ProMED
          • More Periodicals
          • Find a Periodical
          • Go to Product Catalog

          The content on this site is intended for healthcare professionals.



          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
          Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Help & Contact

          RELX